PULSION Medical Systems SE reported earnings results for the nine months of fiscal 2012. For the period, the company reported an increase in EBIT by 34.4% to EUR 7.0 million compared to previous years time period. In the same period revenue growth was 5.3%. As of October 31, 2012 revenue growth stood at 6.3%. In the first three quarters free cash flow increased by 73% to EUR 6.0 million as of September 30, 2012.

The company also provided full year guidance for the full year of 2012. For the year, the company expects revenues to be in a range of EUR 34.0 million to EUR 34.7 million, EBITDA to be in a range of EUR 10.7 million to EUR 11.5 million and EBIT to be in the range of EUR 8.6 million to EUR 9.4 million. Revenue per share diluted to be in a range of 70 cents to 76 cents.